Detalles de la búsqueda
1.
Time from biopsy to radical prostatectomy by race in an equal-access healthcare system: Results from the SEARCH cohort.
Prostate
; 83(11): 1011-1019, 2023 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-37096737
2.
Are associations between obesity and prostate cancer outcomes following radical prostatectomy the same in smokers and non-smokers? Results from the SEARCH Cohort.
Cancer Causes Control
; 34(11): 983-993, 2023 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-37405681
3.
Impact of darolutamide on local symptoms: pre-planned and post hoc analyses of the ARAMIS trial.
BJU Int
; 131(4): 452-460, 2023 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-36087070
4.
Prostate weight and prostate cancer outcomes after radical prostatectomy: Results from the SEARCH cohort study.
Prostate
; 82(3): 366-372, 2022 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-34905632
5.
Association between Delay to Radical Prostatectomy and Clinically Meaningful Outcomes among Patients with Intermediate and High-Risk Localized Prostate Cancer.
J Urol
; 207(3): 592-600, 2022 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-34694910
6.
Efficacy and safety of darolutamide in Black/African-American patients from the phase III ARAMIS study.
Future Oncol
; 18(40): 4473-4482, 2022 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-36753353
7.
Safety of concomitant therapy with radium-223 and abiraterone or enzalutamide in a real-world population.
Prostate
; 81(7): 390-397, 2021 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-33705584
8.
Monocyte counts and prostate cancer outcomes in white and black men: results from the SEARCH database.
Cancer Causes Control
; 32(2): 189-197, 2021 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-33392907
9.
Obesity, race, and long-term prostate cancer outcomes.
Cancer
; 126(16): 3733-3741, 2020 08 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-32497282
10.
Race does not predict skeletal-related events and all-cause mortality in men with castration-resistant prostate cancer.
Cancer
; 126(14): 3274-3280, 2020 07 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-32374476
11.
Follow-up of Prostatectomy versus Observation for Early Prostate Cancer.
N Engl J Med
; 377(2): 132-142, 2017 07 13.
Artículo
en Inglés
| MEDLINE | ID: mdl-28700844
12.
Serum Lipids prior to Starting Androgen Deprivation Therapy and Risk of Castration Resistant Prostate Cancer and Metastasis: Results from the SEARCH Database.
J Urol
; 203(1): 120-127, 2020 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-31430247
13.
Competing Risks of Mortality among Men with Biochemical Recurrence after Radical Prostatectomy.
J Urol
; 204(3): 511-517, 2020 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-32243242
14.
Racial Discrepancies in Overall Survival among Men Treated with 223Radium.
J Urol
; 203(2): 331-337, 2020 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-31479407
15.
Obese men undergoing radical prostatectomy: Is robotic or retropubic better to limit positive surgical margins? Results from SEARCH.
Int J Urol
; 27(10): 851-857, 2020 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-32681540
16.
Influence of African American race on the association between preoperative biopsy grade group and adverse histopathologic features of radical prostatectomy.
Cancer
; 125(17): 3025-3032, 2019 09 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-31042315
17.
Poorly controlled diabetes increases the risk of metastases and castration-resistant prostate cancer in men undergoing radical prostatectomy: Results from the SEARCH database.
Cancer
; 125(16): 2861-2867, 2019 08 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-31034601
18.
Predictors of skeletal-related events and mortality in men with metastatic, castration-resistant prostate cancer: Results from the Shared Equal Access Regional Cancer Hospital (SEARCH) database.
Cancer
; 125(22): 4003-4010, 2019 11 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-31390061
19.
Does race predict the development of metastases in men who receive androgen-deprivation therapy for a biochemical recurrence after radical prostatectomy?
Cancer
; 125(3): 434-441, 2019 02 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-30427535
20.
First-year weight loss with androgen-deprivation therapy increases risks of prostate cancer progression and prostate cancer-specific mortality: results from SEARCH.
Cancer Causes Control
; 30(3): 259-269, 2019 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-30701374